» Articles » PMID: 20943967

The Early Whole-blood Transcriptional Signature of Dengue Virus and Features Associated with Progression to Dengue Shock Syndrome in Vietnamese Children and Young Adults

Abstract

Dengue is a pantropic public health problem. In children, dengue shock syndrome (DSS) is the most common life-threatening complication. The ability to predict which patients may develop DSS may improve triage and treatment. To this end, we conducted a nested case-control comparison of the early host transcriptional features in 24 DSS patients and 56 sex-, age-, and virus serotype-matched uncomplicated (UC) dengue patients. In the first instance, we defined the "early dengue" profile. The transcriptional signature in acute rather than convalescent samples (≤72 h post-illness onset) was defined by an overabundance of interferon-inducible transcripts (31% of the 551 overabundant transcripts) and canonical gene ontology terms that included the following: response to virus, immune response, innate immune response, and inflammatory response. Pathway and network analyses identified STAT1, STAT2, STAT3, IRF7, IRF9, IRF1, CEBPB, and SP1 as key transcriptional factors mediating the early response. Strikingly, the only difference in the transcriptional signatures of early DSS and UC dengue cases was the greater abundance of several neutrophil-associated transcripts in patients who progressed to DSS, a finding supported by higher plasma concentrations of several canonical proteins associated with neutrophil degranulation (bactericidal/permeability-increasing protein [BPI], elastase 2 [ELA2], and defensin 1 alpha [DEF1A]). Elevated levels of neutrophil-associated transcripts were independent of the neutrophil count and also of the genotype of the infecting virus, as genome-length sequences of dengue virus serotype 1 (DENV-1) (n = 15) and DENV-2 (n = 3) sampled from DSS patients were phylogenetically indistinguishable from those sampled from uncomplicated dengue patients (32 DENV-1 and 9 DENV-2 sequences). Collectively, these data suggest a hitherto unrecognized association between neutrophil activation, pathogenesis, and the development of DSS and point to future strategies for guiding prognosis.

Citing Articles

Whole-blood model reveals granulocytes as key sites of dengue virus propagation, expanding understanding of disease pathogenesis.

Praneechit H, Thiemmeca S, Prayongkul D, Kongmanas K, Mairiang D, Punyadee N mBio. 2024; 15(12):e0150524.

PMID: 39540772 PMC: 11633123. DOI: 10.1128/mbio.01505-24.


Immunological signatures unveiled by integrative systems vaccinology characterization of dengue vaccination trials and natural infection.

Placa D, Fonseca D, Marques A, Zaki Pour S, Usuda J, Baiocchi G Front Immunol. 2024; 15:1282754.

PMID: 38444851 PMC: 10912564. DOI: 10.3389/fimmu.2024.1282754.


The dengue-specific immune response and antibody identification with machine learning.

Natali E, Horst A, Meier P, Greiff V, Nuvolone M, Babrak L NPJ Vaccines. 2024; 9(1):16.

PMID: 38245547 PMC: 10799860. DOI: 10.1038/s41541-023-00788-7.


saliva modulates inflammasome activation and facilitates flavivirus infection .

Shrivastava G, Valenzuela-Leon P, Botello K, Calvo E iScience. 2024; 27(1):108620.

PMID: 38188518 PMC: 10770497. DOI: 10.1016/j.isci.2023.108620.


Interferome signature dynamics during the anti-dengue immune response: a systems biology characterization.

Usuda J, Placa D, Fonseca D, Marques A, Filgueiras I, Chaves V Front Immunol. 2023; 14:1243516.

PMID: 37638052 PMC: 10449254. DOI: 10.3389/fimmu.2023.1243516.


References
1.
Hartshorn K, White M, Tecle T, Holmskov U, Crouch E . Innate defense against influenza A virus: activity of human neutrophil defensins and interactions of defensins with surfactant protein D. J Immunol. 2006; 176(11):6962-72. DOI: 10.4049/jimmunol.176.11.6962. View

2.
Joshi-Tope G, Gillespie M, Vastrik I, DEustachio P, Schmidt E, de Bono B . Reactome: a knowledgebase of biological pathways. Nucleic Acids Res. 2004; 33(Database issue):D428-32. PMC: 540026. DOI: 10.1093/nar/gki072. View

3.
Coffey L, Mertens E, Brehin A, Fernandez-Garcia M, Amara A, Despres P . Human genetic determinants of dengue virus susceptibility. Microbes Infect. 2009; 11(2):143-56. DOI: 10.1016/j.micinf.2008.12.006. View

4.
Bethell D, Gamble J, Pham P, Nguyen M, Tran T, Ha T . Noninvasive measurement of microvascular leakage in patients with dengue hemorrhagic fever. Clin Infect Dis. 2001; 32(2):243-53. DOI: 10.1086/318453. View

5.
Graham R, Juffrie M, Tan R, Hayes C, Laksono I, Maroef C . A prospective seroepidemiologic study on dengue in children four to nine years of age in Yogyakarta, Indonesia I. studies in 1995-1996. Am J Trop Med Hyg. 1999; 61(3):412-9. DOI: 10.4269/ajtmh.1999.61.412. View